IMC Chicago
UTHR icon

IMC Chicago’s United Therapeutics UTHR Stock Holding History

IMC Chicago’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Sell
34,800
-63,000
-64% -$35.5M ﹤0.01% 1094
2026
Q1 		$58M Buy
97,800
+52,000
+114% +$25.9M 0.02% 451
2025
Q4 		$22.3M Buy
45,800
+12,900
+39% +$6.01M 0.01% 795
2025
Q3 		$13.8M Buy
32,900
+10,400
+46% +$3.5M 0.01% 966
2025
Q2 		$6.47M Buy
+22,500
New +$6.72M ﹤0.01% 1244

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

IMC Chicago's UTHR Position: Q2 2026 in Review

IMC Chicago reduced its United Therapeutics (UTHR) stake by 71% in Q2 2026, selling an estimated $8.81M and leaving 6,521 shares worth $3.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2477.

IMC Chicago first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.1M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • IMC Chicago held 6,521 shares of United Therapeutics worth $3.53M as of Q2 2026.
  • IMC Chicago sold 15,641 United Therapeutics shares in Q2 2026, an estimated $8.81M.
  • United Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2477 holding.
  • IMC Chicago first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • IMC Chicago's United Therapeutics position peaked at $13.1M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.